🔄 Return-to-therapy · adherence · re-engagement
REJOINRX.COM
Built for the second start: helping patients come back to their therapy 🔄
Patients stop therapies for cost, side effects or simple drift, and many later restart. RejoinRx.com is a warm, non-judgmental name for the programs that help them come back: adherence outreach, re-enrollment and refill win-back.
- 🔄 “Rejoin” is welcoming
- 💬 Great for outreach campaigns
- 📈 Adherence & retention focus
ℹ️ Independent listing — not affiliated with any person, school, company, campaign or party named or suggested by the domain. Details below.
Why REJOINRX.COM? 🔄
Stopping and restarting is common. In a large JAMA Network Open cohort, most adults with overweight or obesity who began a GLP-1 therapy had stopped within a year, and many restarted later[1]. Cost is a big reason people fall off: KFF finds 43% of U.S. adults have not taken a medication as prescribed in the past year because of cost[2]. RejoinRx.com gives re-engagement programs a friendly front door.
Welcoming, not scolding
“Rejoin” invites people back. It reads better in an outreach email than “non-adherence.”
Matches a measured problem
Discontinuation and reinitiation are now tracked in peer-reviewed research[1].
Fits cost-driven gaps
Affordability is the reason many patients leave therapy[2], so a rejoin program can bundle savings and support.
Clear and easy to remember
Two everyday words, easy to say on a phone call and to print on a mailer.
The market, by the numbers 📊
Every figure links to its source in the References section below.
Who buys REJOINRX.COM 🎯
Pharmacies & PBMs
Refill win-back and adherence programs that reach lapsed members.
Weight-management & chronic-care programs
Re-enrollment funnels for patients restarting a care plan with their clinician.
Patient-engagement platforms
Outreach software (SMS, IVR, email) that needs a branded landing domain.
Manufacturer access programs
Re-onboarding into support and savings programs after a gap in coverage.
Launch ideas 🚀
“Welcome back” re-enrollment flow
Check coverage, update insurance and reconnect with a pharmacist in one session.
Lapsed-refill outreach
Personal SMS/email campaigns that land on a reassuring page.
Cost-barrier navigator
Shows savings options for patients who stopped because of price.
Education hub
Plain-language content on talking with your clinician about restarting a treatment plan.
BUY NOW - $26,510
Buy Now — REJOINRX.COM. Own the Rejoin Rx hostname.
MAKE AN OFFERPurchase REJOINRX.COM today through our trusted partners:
WHAT DOES AXEL IVERS THINK?
"Retention is the most valuable growth lever in pharmacy, and RejoinRx.com gives it a name patients actually respond to."
Axel Ivers, IT Specialist
Contact Axel Ivers via Email
FAQs
Who buys RejoinRx.com?
Pharmacies, PBMs, chronic-care and weight-management programs, and patient-engagement platforms running re-enrollment or adherence outreach.
Is “returning to therapy” a measurable market need?
Yes. A JAMA Network Open study of 125,474 adults found 53.6% discontinued GLP-1 therapy within a year, and many later restarted[1].
Why does cost matter here?
KFF reports 43% of U.S. adults have not taken medication as prescribed in the past year because of cost[2], so savings support is a natural part of a rejoin program.
Does the page make any treatment claims?
No. RejoinRx.com is offered as a brand asset only; any restart decision belongs to patients and their clinicians.
How do I buy?
Make an offer by email or buy through GoDaddy or Afternic.
Contact Us
Feel free to reach out to explore the potentials of REJOINRX.COM for your business. 📬
📧 Email: info@xeladomains.com
📞 Phone: (858) 429-9352
REFERENCES
- Rodriguez et al., JAMA Network Open (2025) — “Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity” (PMC full text)
- KFF Health Tracking Poll — “Public Views on Prescription Drug Costs: Regulation, Affordability and TrumpRx” (2026)
- ASHP via PR Newswire (Apr 30, 2026) — “U.S. Prescription Drug Spending Poised to Cross $1 Trillion”: 2025 spending rose 12.7% to $915 billion
Social Networks
Follow us on Instagram and LinkedIn for updates and more information.
Instagram | LinkedIn